BRK-B vs CRBG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Corebridge Financial exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a low forward P/E of 4.47 and bullish analyst targets, the company is suffering from a severe earnings collapse (-58.10% YoY) and consistent quarterly misses. Massive insider selling totaling over $1.76 billion suggests a lack of confidence from major stakeholders. The combination of negative ROE and a dangerously low quick ratio (0.24) points toward a potential value trap.
Compare Another Pair
Related Comparisons
BRK-B vs CRBG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Corebridge Financial, Inc. (CRBG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.